Crinetics Pharmaceuticals, Inc. - Common Stock (NQ:CRNX)

Crinetics Pharmaceuticals to Participate in Upcoming Investor Conferences

November 20, 2023

Crinetics Pharmaceuticals Announces November 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

8 Analysts Have This to Say About Crinetics Pharmaceuticals ↗

November 20, 2023

Via Benzinga

November 10, 2023

Crinetics Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update

11 Analysts Have This to Say About Crinetics Pharmaceuticals ↗

October 24, 2023

Via Benzinga

November 07, 2023

Young Adults and Pancreatic Cancer: What the 80% Rise in Diagnoses Means for Future Treatment

October 11, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GNLX),(NASDAQ:CRNX),(NYSE:PFE),(NASDAQ:SGEN) EQNX::TICKER_END

Via FinancialNewsMedia

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 10, 2023

A positive late-stage trial readout fueled a major rally in the drugmaker's shares.

Why Crinetics Pharmaceuticals Stock Soared This Week ↗

September 15, 2023

Via The Motley Fool

Crinetics Pharmaceuticals Inc. (NASDAQ: CRNX) Near the Top of Equities by Percentage Gain on 9/11

September 11, 2023

Via Investor Brand Network

10 Health Care Stocks Whale Activity In Today's Session ↗

October 09, 2023

Via Benzinga

7 Speculative Stocks Set to Explode Higher ↗

October 03, 2023

On the search for high-risk, high-reward opportunities? Consider taking a look at these seven speculative stocks.

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Top 4 Health Care Stocks That Should Keep You Up At Night ↗

September 21, 2023

Via Benzinga

Crinetics Pharmaceuticals to Participate in the Cantor Global Healthcare Conference 2023

September 20, 2023

Despite good results in phase 3 trials, there are barriers to its drug candidate's success.

Up 83% in 5 Days, Is Crinetics Pharmaceuticals a Buy? ↗

September 19, 2023

Via The Motley Fool

Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

September 12, 2023

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) shares are trading higher Tuesday.

What's Going On With Crinetics Pharmaceuticals Stock? ↗

September 12, 2023

Via Benzinga

Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock

September 11, 2023

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 1% on Monday. The Dow traded up 0.29% to 34,676.52 while the NASDAQ rose 1.16% to 13,920.60. The S&P...

Nasdaq Rises Over 1%; Hostess Brands Shares Spike Higher ↗

September 11, 2023

Via Benzinga

Topics Stocks

Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

September 11, 2023

Gainers Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) jumped 76% to $28.13 after the company's once-daily oral paltusotine achieved the primary and secondary endpoints in the Phase 3 PATHFNDR-1 study...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 11, 2023

Via Benzinga

Why Shares of Crinetics Pharmaceuticals Are Jumping Monday ↗

September 11, 2023

The biotech company reported positive phase 3 trial results.

Via The Motley Fool

Gold Edges Higher; Virco Manufacturing Shares Surge After Q2 Results ↗

September 11, 2023

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 80 points on Monday. The Dow traded up 0.40% to 34,715.88 while the NASDAQ rose 0.58% to 13,841.50. The S&P...

Via Benzinga

Topics Stocks

Crinetics Pharma's Investigational Candidate Shows Promise In Rare Type Of Hormonal Disorder ↗

September 11, 2023

On Sunday, Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) said its Phase 3 PATHFNDR-1 study evaluating paltusotine met the primary and secondary

Via Benzinga

Crinetics Pharmaceuticals Just Scored A Much-Needed Win And Soared 71% ↗

September 11, 2023

The company is working on a treatment for a growth hormone disorder.

Via Investor's Business Daily

US Stocks Open Higher; Dow Jumps 150 Points ↗

September 11, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining around 150 points on Monday. Following the market opening Monday, the Dow traded up 0.46% to 34,736.26 while the NASDAQ rose 0.94% to...

Via Benzinga

Topics Stocks

Why Is Nuwellis (NUWE) Stock Down Today? ↗

September 11, 2023

Nuwellis (NUWE) stock is taking a beating on Monday despite a lack of news or increased trading activity for the medical device company.

Tenon Medical (TNON) stock is falling on Monday after the surgical implant company announced a proposed public offering for its shares.

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 11, 2023

Via Benzinga

Why Is Tenon Medical (TNON) Stock Down 30% Today? ↗

September 11, 2023

Versus Systems (VS) stock is rising higher on Monday as the business software company's shares experience heavy trading this morning.

Why Is Versus Systems (VS) Stock Up 17% Today? ↗

September 11, 2023